Where Will DURECT Corp (DRRX) Stock Go Next After It Has Fallen 1.60% in a Week?

Overall market sentiment has been high on DURECT Corp (DRRX) stock lately. DRRX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

DURECT Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on DRRX!

See Full DRRX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With DRRX Stock Today?

DURECT Corp (DRRX) stock has fallen -8.22% while the S&P 500 is higher by 0.08% as of 9:53 AM on Thursday, Mar 28. DRRX is lower by -$0.11 from the previous closing price of $1.34 on volume of 25,432 shares. Over the past year the S&P 500 is up 32.27% while DRRX is lower by -70.71%. DRRX lost -$1.05 per share in the over the last 12 months.

More About DURECT Corp

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States. Click Here to get the full Stock Report for DURECT Corp stock.